stage IV esophageal cancer
Showing 9976 - 10000 of >10,000
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- vismodegib
- +6 more
-
Scottsdale, Arizona
- +2 more
Apr 4, 2019
HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)
Not yet recruiting
- HER2-positive Breast Cancer
- 68Ga/131I-SGMIB-5F7
-
Shanghai, ChinaHuashan Hospital
Aug 1, 2023
Data Acquisition for Connected Network for EMSs Comprehensive
Completed
- Emergency Patients Being Transported by Rescue Ambulance
-
Seoul, Korea, Republic ofSeverance hospital
Jul 3, 2023
Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing
Recruiting
- Carcinoma
- +4 more
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Jun 30, 2023
Prostate Cancer Trial in Herlev (Focal Brachytherapy)
Enrolling by invitation
- Prostate Cancer
- Focal Brachytherapy
-
Herlev, DenmarkDepartment of Urology, Herlev University Hospital Herlev
Oct 12, 2023
Breast Cancer Female Trial in Coimbra (Mind, Support Group)
Recruiting
- Breast Cancer Female
- Mind
- Support Group
-
Coimbra, PortugalRadiotherapy Service of the Coimbra University Hospital (CHUC)
Jan 16, 2023
Prostate Cancer, Magnetic Resonance Imaging, Population at Risk Trial in Lake Success (Bi-parametric MRI)
Recruiting
- Prostate Cancer
- +2 more
- Bi-parametric MRI
-
Lake Success, New YorkCynthia Knauer
Aug 26, 2022
Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)
Active, not recruiting
- Breast Cancer
- HKI-272
- +3 more
-
San Francisco, California
- +17 more
Jan 30, 2023
Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- PF-07220060
- +3 more
- (no location specified)
Oct 24, 2023
Lymphoma Trial in Worldwide (immunoscintigraphy, technetium Tc 99m epratuzumab)
Unknown status
- Lymphoma
- immunoscintigraphy
- technetium Tc 99m epratuzumab
-
Los Angeles, California
- +7 more
Aug 12, 2021
Interstitial Lung Disease Within a Lung Cancer Screening
Completed
- Interstitial Lung Disease
-
Manchester, Greater Manchester, United KingdomManchester University NHS foundation trust
Jan 14, 2021
Tailoring Shared Decision Making for Lung Cancer Screening in
Enrolling by invitation
- Lung Carcinoma
- Behavioral Intervention
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 23, 2022
Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Philadelphia (drug, procedure, other)
Recruiting
- Recurrent Renal Cell Carcinoma
- Renal Cell Carcinoma
- Sulfur Hexafluoride Lipid Microspheres
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 29, 2022
Cancer, Lung, Cancer, Head and Neck Trial in Denver, Grand Junction (Stepped-Care Intervention, Enhanced Usual Care)
Completed
- Cancer, Lung
- Cancer, Head and Neck
- Stepped-Care Intervention
- Enhanced Usual Care
-
Denver, Colorado
- +4 more
Feb 24, 2021
Hepatocellular Carcinoma Trial in New Taipei City, Hualien City, Taipei (ATL administration)
Recruiting
- Hepatocellular Carcinoma
- ATL administration
-
New Taipei City, Taiwan (R. O. C.), Taiwan
- +3 more
Jun 10, 2022
Hyperkalemia, End Stage Renal Disease Trial in Durham (Patiromer Oral Powder Product)
Enrolling by invitation
- Hyperkalemia
- End Stage Renal Disease
- Patiromer Oral Powder Product
-
Durham, North CarolinaDaVita Dialysis Sites
Jun 10, 2022
Bipolar Disorder, Non-Adherence, Medication, Hypertension Trial in Cleveland (iTAB-CV, Self-Monitoring)
Recruiting
- Bipolar Disorder
- +2 more
- iTAB-CV
- Self-Monitoring
-
Cleveland, OhioCase Western Reserve University
Jul 22, 2022
Distress, Emotional, Sleep Trial in Taipei (Kombucha)
Recruiting
- Distress, Emotional
- Sleep
- Kombucha
-
Taipei, TaiwanNational Yang-Ming University
Feb 6, 2023
Brentuximab Vedotin for IV Infusion - Special Drug Use
Completed
- Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma
- Brentuximab vedotin (recombinant)
-
Osaka, Japan(unnamed)
Jun 25, 2020
Barrett Esophagus Trial in Groningen (Bevacizumab-IRDye800CW, Fluorescence endoscopy)
Recruiting
- Barrett Esophagus
- Bevacizumab-IRDye800CW
- Fluorescence endoscopy
-
Groningen, NetherlandsUniversity Medical Center Groningen
Nov 3, 2020
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Canada, United States (other, device, behavioral)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Educational Intervention
- +5 more
-
Mobile, Alabama
- +110 more
Jan 30, 2023
Lung Non-Small Cell Carcinoma Trial in Buffalo (Pembrolizumab)
Active, not recruiting
- Lung Non-Small Cell Carcinoma
- Pembrolizumab
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 27, 2023
Evaluating Disparities in Precision Oncology
Not yet recruiting
- Metastatic Cancer
- Advanced Cancer
- Social Determinants of Health and toxicity questionnaires
-
Indianapolis, IndianaIndiana University Health Melvin and Bren Simon Comprehensive Ca
Oct 7, 2023